SLC1A5 and neoplasm: Recent studies have suggested that the inhibition of glutamine metabolism can potentiate the effects of metformin, reducing growth and inhibiting tumor progression16,17, in addition to showing that the downregulation of glutamine transporter (alanine, serine, cysteine-preferring transporter 2, ASCT2/SLC1A5) could suppress proliferation and induce apoptosis in CRC cell lines18.